Reversal of reserpine-induced catalepsy
β
C. Anthony Hubbard; Dr. Joel M. Trugman
π
Article
π
1993
π
John Wiley and Sons
π
English
β 601 KB
## Abstract To gain insight into the antiparkinsonian effects of selective D1 and D2 dopamine receptor stimulation, we examined the ability of D1 (SKF 38393) and D2 (quinpirole) agonists to reverse catalepsy induced by the combined administration of reserpine and Ξ±βmethylβpβtyrosine (AMPT) in rats.